Jeffery J Feigenbaum

Title: Jeffery J Feigenbaum: Innovator in Pharmaceutical Compositions

Introduction

Jeffery J Feigenbaum is a notable inventor based in Jerusalem, IL. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work focuses on creating effective medications that minimize side effects.

Latest Patents

Feigenbaum's latest patents include innovative formulations such as (3S-4S)-7-hydroxy-.DELTA..sup.6 -tetrahydrocannabinols. This invention relates to novel homologues and derivatives that are essentially free of the (3R,4R) form. The pharmaceutical compositions derived from these compounds exhibit potent analgesic, antiemetic, and antiglaucoma effects. Importantly, these compositions are designed to be devoid of the undesired psychotropic effects associated with the (3R,4R) type compounds. They are particularly useful in treating both acute and chronic pain. Another significant patent involves the development of 3-(6-alkoxy-4-alkyl-2-hydroxyphenyl) cyclohexanol derivatives, which serve as potent analgesics and antiemetics without psychotropic activity.

Career Highlights

Throughout his career, Feigenbaum has been associated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has contributed to advancements in pharmaceutical research and development, focusing on creating effective and safe medications.

Collaborations

Feigenbaum has collaborated with prominent figures in the field, including Raphael Mechoulam and Naphtali Lander. These partnerships have enhanced the impact of his research and innovations.

Conclusion

Jeffery J Feigenbaum's contributions to pharmaceutical innovations highlight his commitment to developing effective treatments with minimal side effects. His work continues to influence the field and improve patient care.